dr. levis on gilteritinib in relapsed/refractory flt3-mutated aml
Published 4 years ago • 1K plays • Length 2:28Download video MP4
Download video MP3
Similar videos
-
6:38
relapsed/refractory flt3-mutated aml
-
1:37
emerging mutations at relapse in flt3-mutated r/r aml on gilteritinib
-
1:48
dr. levis on the challenges of treating flt3-itd aml
-
10:54
gilteritinib for flt3-mutant aml
-
1:18
dr. levis discusses the ideal use of quizartinib in flt3-itd aml
-
6:18
previously untreated flt3-mutated aml
-
1:24
mark levis, md, phd, discusses what we've learned about gilteritinib in flt3 mutated aml patients
-
1:09
dr. altman on gilteritinib in patients with relapsed/refractory aml
-
1:33
is gilteritinib the new breakthrough in the treatment of flt3-mutated aml?
-
2:33
dr. levis discusses quizartinib in aml
-
1:06
gilteritinib monotherapy shows potential for treatment of relapsed/refractory flt3 aml
-
3:01
admiral: gilteritinib for r/r flt3-mutated aml
-
7:26
targeting flt3 in patients with relapsed/refractory aml
-
1:57
dr. levis on the challenges of treating flt3-itd aml
-
1:50
mechanisms of gilteritinib resistance in flt3-mutated aml
-
3:00
impact of genetic mutations in gilteritinib treated patients with flt-3 mutated r/r aml
-
1:33
what effect does gilteritinib have on flt3 mutated relapsed/refractory aml?
-
6:51
aml on the go - selective inhibition of flt3 by gilteritinib
-
2:12
mrd and cr impact survival in gilteritinib-treated flt3 r/r aml